Share This Article:

Synthesis of Fluorinated Heterobicyclic Nitrogen Systems Containing 1,2,4-Triazine Moiety as CDK2 Inhibition Agents

Abstract Full-Text HTML XML Download Download as PDF (Size:408KB) PP. 200-211
DOI: 10.4236/ijoc.2015.53020    4,132 Downloads   4,894 Views   Citations

ABSTRACT

New fluorine substituted heterobicyclic nitrogen system as imidozolopyrimidines (2,3), pyrimido- 1,2,4-triazinones (4-7), 1,2,4-triazinyl-1,2,4-triazine (12-16), 1,2,4-triazinyl-1,2,4-triazinones (14-17) and substituted thiobarbituric acids (19-20), have been synthesized using the reaction of 3- amino-5,6-di (4'-fluorophenyl)-1,2,4-triazine (1) with α,β–bifunctional compounds. Structures of the title compounds were characterized by UV, IR, 1H/13C-NMR and mass spectrometric method. The studied compounds were tested for CDK2 inhibiting activity in DNA damage, as well as in vitro anti-tumor activity.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Makki, M. , Abdel-Rahman, R. and Aqlan, F. (2015) Synthesis of Fluorinated Heterobicyclic Nitrogen Systems Containing 1,2,4-Triazine Moiety as CDK2 Inhibition Agents. International Journal of Organic Chemistry, 5, 200-211. doi: 10.4236/ijoc.2015.53020.

References

[1] Fuchs, T., Chowdhury, G., Barnes, C.L. and Gates, K.S. (2001) 3-Amino-1,2,4-benzotriazine 4-Oxide: Characterization of a New Metabolite Arising from Bioreductive Processing of the Antitumor Agent 3-Amino-1,2,4-benzotriazine 1,4-Dioxide (Tirapazamine). The Journal of Organic Chemistry, 66, 107-114.
http://dx.doi.org/10.1021/jo001232j
[2] Leach, M., Marden, C. and Miller, A. (1986) Pharmacological Studies on Lamotrigine, a Novel Potential Anti-Epileptic Drug: II Neuro-chemical Studies on the Mechanism of Action. Epilepsia, 27, 490-497.
http://dx.doi.org/10.1111/j.1528-1157.1986.tb03573.x
[3] Ibrahim, M.A., Abdel-Rahman, R.M., Abdel-Halim, A.M., Ibrahim, S.S. and Allimony, H.A. (2008) Synthesis and Antifungal Activity of Novel Polyheterocyclic Compounds Containing 1,2,4-Triazine Moiety. Arkivoc, Xvi, 202-215.
[4] Abdel-Rahman, R.M., Makki, M.S.T., Ali, T.E. and Ibrahim, M.A. (2012) 1,2,4-Triazine Chemistry Part III: Synthetic Strategies to Functionalized Bridgehead Nitrogen Heteroannulated 1,2,4-Triazine Systems and Their Regiospecific and Pharmacological Properties, Current Org. Synthesis, 9, 1-25. The Merck Index & Co. Inc., White house Station, NJ, USA, (2006) 1953.
[5] Abdel-Rahman, R.M. (2001) Rrole of Uncondensed 1,2,4-Triazine Compounds and Related Heterocyclic Systems as Therapeutic Agents. Pharmazie, 56, 18-30.
[6] Abdel-Rahman, R.M. (1991) Synthesis and Anti Human Immune Virus Activity of Some New Fluorine Containing Substituted 3-Thioxo-1,2,4-triazin-5-ones, Farmaco, 46, 379-389.
[7] Mamolo, M.G., Falagiani, V., Zampieri, D., Vio, L. and Banfi, E. (2000) Synthesis and Antimycobacterial Activity of Some 4H-1,2,4-Triazin-5-one Derivatives. Il Farmaco, 55, 590-595.
http://dx.doi.org/10.1016/S0014-827X(00)00074-4
[8] Abdel-Rahman, R.M., Morsy, J.M., Hanafy, F.I. and Amine, H.A. (1999) Synthesis of Heterobicyclic Nitrogen Systems Bearing the 1,2,4-Triazine Moiety as Anti-HIV and Anticancer Drugs; Part I. Pharmazie, 54, 347-351.
[9] Liu, K.C.H., Shih, Bi-J. and Lee, Ch-Hs (1993) Synthesis of Representative 10-aryl-, 10-Aralkyl- and 10-Heteroaryl-9H-naphtha[1′,2′:4,5]thiazolo[3,2-b][1,2,4]triazin-9-ones as Potential Anti HIV Agents. Journal of Heterocyclic Chemistry, 10, 1331-1335.
http://dx.doi.org/10.1002/jhet.5570300525
[10] Russell, M.G., Carling, R.W., Street, L.J., Hallett, D.J., Goodacre, S., Mezzogori, E., Reader, M., Cook, S.M., Bromidge, F.A., Newman, R., Smith, A.J., Wafford, K.A., Marshall, G.R., Reynolds, D.S., Dias, R., Ferris, P., Stanley, J., Lincoln, R., Tye, S.J., Sheppard, W.F., Sohal, B., Pike, A., Dominguez, M., Atack, J.R. and Castro, J.L. (2006) Discovery of Imidazo[1,2-b][1,2,4]triazines as GABA(A) alpha2/3 Subtype Selective Agonists for the Treatment of Anxiety. Journal of Medical Chemistry, 49, 1235-1238.
http://dx.doi.org/10.1021/jm051200u
[11] Koek, W., Patoiseau, J.F., Assie, M.B., Cosi, C. and Kleven, M.S. Dupont-Passelaigue, E., Carilla-Durand, E., Palmier, C., Valentin, J.P., John, G., Pauwels, P. J., Tarayre, J.-P. and Colpaert, F.C. (1998) F 11440, a Potent, Selective, High Efficacy 5-HT1A Receptor Agonist with Marked Anxiolytic and Anti-Depressant Potential. Journal of Pharmacology and Experimental Therapeutics, 287, 266-283.
[12] El-Gendy, Z., Morsy, J., Allimony, H.A., Abdel-Monem, W. R. and Abdel-Rahman R. M. (2001) Synthesis of Heterobicyclic Nitrogen Systems Bearing the 1,2,4-Triazine Moiety as anti HIV and Anticancer Drugs, Part III. Pharmazie, 56, 376-382.
[13] El-Gendy, Z., Morsy, J.M., Allimony, H.A., Abdel-Monem, W.R. and Abdel-Rahman R.M. (2003) Synthesis of heterobicyclic nitrogen systems bearing a 1,2,4-triazine moiety as anticancer drugs, Part IV. Phosphorus, Sulfur, and Silicon and the Related Elements, 178, 2055-2071.
http://dx.doi.org/10.1080/10426500390228738
[14] Abdel-Rahman, R.M., Morsy, J., El-Edfawy, S. and Amine, H.A. (1999) Synthesis of Some Heterobicyclic Nitrogen Systems Bearing the 1,2,4-Triazine Moiety as Anti HIV and Anticancer Drugs, Part II. Pharmazie, 54, 667-671.
[15] Mohared, R.M., Ibrahim, R.A. and Moustafa, H.E. (2010) Hydrazide-Hydrazones in the Synthesis of 1,3,4-Oxadiazine, 1,2,4-Triazine and Pyrazole Derivatives with Antitumor Activities. The Open Organic Chemistry Journal, 4, 8-14.
[16] El-Nagger, S.A., El-Barbary, A.A., Mansour, M.A., Abdel-Shafy, F. and Talat S. (2011) Anti-Tumor Activity of Some 1,3,4-Thiadiazoles and 1,2,4-Triazine Derivatives against Ehrlichs Ascites Carcinoma. International Journal of Cancer Research, 7, 278-288.
http://dx.doi.org/10.3923/ijcr.2011.278.288
[17] Smart, B.E. (2001) Fluorine Substituent Effects (on Bioactivity). Journal of Fluorine Chemistry, 109, 3-11.
http://dx.doi.org/10.1016/S0022-1139(01)00375-X
[18] Ismail, F.M.D. (2002) Important Fluorinated Drugs in Experimental and Clinical Use. Journal of Fluorine Chemistry, 118, 27-33.
http://dx.doi.org/10.1016/S0022-1139(02)00201-4
[19] Dolbier Jr., W.R. (2005) Fluorine Chemistry at the Millennium. Journal of Fluorine Chemistry, 126, 157-163.
http://dx.doi.org/10.1016/j.jfluchem.2004.09.033
[20] Isanbor, C. and O’Hagan, D. (2006) Fluorine in Medicinal Chemistry: A Review of Anti-Cancer Agents. Journal of Fluorine Chemistry, 127, 303-319.
http://dx.doi.org/10.1016/j.jfluchem.2006.01.011
[21] Abdel-Rahman, R.M. (2001) Synthesis and Chemistry of Fluorine Containing 1,2,4-Triazine. Pharmazie, 56, 791-804.
[22] Workman, P. (2005) Genomics and the Second Golden Era of Cancer Drug Development. Molecular BioSystems, 1, 17-26.
http://dx.doi.org/10.1039/b501751n
[23] Morgan, D.O. (1997) Cyclin-Dependent Kinases: Engines, Clocks, and Microprocessors. Annual Review of Cell and Developmental Biology, 13, 261-291.
http://dx.doi.org/10.1146/annurev.cellbio.13.1.261
[24] Satyanarayana, A. and Kaldis, P. (2009) A Dual Role of Cdk2 in DNA Damage Response. Cell Division, 4, 9.
http://dx.doi.org/10.1186/1747-1028-4-9
[25] Abdel-Rahman, R.M. (1999) Chemistry of Uncondensed 1,2,4-Triazines Part I, Chemical Reactivity of 5,6-Diphenyl- 1,2,4-triazine-5-yl Containing Active Groups. Trends in Heterocyclic Chemistry, 6, 126-133.
[26] Abdel-Rahman, R.M. (2001) Chemistry of Uncondensed 1,2,4-Triazines Part IV. Synthesis and Chemistry of Bioactive 3-Amino-1,2,4-triazines and Related Compounds. Pharmaize, 56, 275-286.
[27] Musator, D.M., Kurilor, D.V. and Rakisher, A.K. (2008) Efficient Synthesis of 3-Amino-5,6-diphenyl-1,2,4-triazine. Ukrainica Bioorganica Act, 1, 61-62.
[28] Hwang, L.-C., Wu, R.-R., Jane, S.-Y. and Lee, G.-H. (2003) Crystals Structure of 3-Amino-1,2,4-triazine. Analytical Sciences, 19, x73-x74.
http://dx.doi.org/10.2116/analscix.19.x73
[29] Palmer, M.H., Preston, P.N. and Steven, M.F.G. (1971) The Mass Spectra of 1,2,4-Triazines and Related Compounds. Organic Mass Spectrometry, 5, 1085-1092.
http://dx.doi.org/10.1002/oms.1210050908

  
comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.